Leiping Wang

发表

A phase II trial of biweekly vinorelbine and oxaliplatin in second- or third-line metastatic triple-negative breast cancer

Z. Shao, Jian Zhang, Leiping Wang, 2015, Cancer biology & therapy.

Vinorelbine and capecitabine in anthracycline- and/or taxane-pretreated metastatic breast cancer: sequential or combinational?

Jialei Wang, Jian Zhang, Leiping Wang, 2012, Cancer Chemotherapy and Pharmacology.

Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple-negative metastatic breast cancer

S. Zhang, Z. Shao, Jian Zhang, 2017, Oncotarget.

Hypothyroidism as a potential biomarker of efficacy of famitinib, a novel VEGFR-2 inhibitor in metastatic breast cancer

Jian Zhang, Leiping Wang, Zhonghua Wang, 2014, Cancer Chemotherapy and Pharmacology.

OP0001 Hypothyroidism as a potential biomarker of efficacy of famitinib, a novel VEGFR2 inhibitor in metastatic breast cancer

Jian Zhang, Leiping Wang, Zhonghua Wang, 2014 .

Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial

S. Zhang, J. Ragaz, Si Sun, 2015, PloS one.

Jian Zhang, Leiping Wang, Xichun Hu, 2021 .

Dalpiciclib Combined With Pyrotinib and Letrozole in Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer (LORDSHIPS): A Phase Ib Study

W. Yao, Ting Li, Jian Zhang, 2022, Frontiers in Oncology.

Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L

Lin Guo, Xiang Gao, Jian Zhang, 2016, Tumor Biology.

Phase II Study of Pseudomonas aeruginosa-Mannose-Sensitive Hemagglutinin in Combination with Capecitabine for Her-2–Negative Metastatic Breast Cancer Pretreated with Anthracycline and Taxane

Z. Shao, Jian Zhang, Leiping Wang, 2015, PloS one.

Apatinib plus vinorelbine versus vinorelbine for metastatic triple-negative breast cancer who failed first/second-line treatment: the NAN trial

Jian Zhang, Leiping Wang, Xichun Hu, 2022, npj Breast Cancer.

A retrospective analysis of outcomes for primary mediastinal large B-cell lymphoma treated with RCHOP followed by radiotherapy or front-line autologous stem cell transplantation

T. Deng, Jumei Shi, Jian Zhang, 2017, Hematology.

Phase II study of chidamide in combination with cisplatin in patients with metastatic triple-negative breast cancer.

Ting Li, Jian Zhang, Leiping Wang, 2021, Annals of palliative medicine.

Complete remission of primary bilateral adrenal lymphoma achieved by Rituximab-CHOP chemotherapy

Peng Li, Y. Yang, Leiping Wang, 2011 .

TCRM_A_255365 607..615

Jian Zhang, Leiping Wang, Xichun Hu, 2020 .

Phase 1b clinical trial of pucotenlimab (HX008), a novel anti-PD-1 monoclonal antibody, combined with gemcitabine and cisplatin in the first-line treatment of metastatic triple-negative breast cancer

Jian Zhang, Leiping Wang, Xichun Hu, 2022, Frontiers in Oncology.

Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia

Bao-ying Yuan, Ting Li, Yizi Jin, 2019, Breast Cancer Research and Treatment.

Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study

L. Cai, P. Shen, Yue-Yin Pan, 2018, Breast Cancer Research and Treatment.

Temporal Heterogeneity of HER2 Expression and Spatial Heterogeneity of 18F-FDG Uptake Predicts Treatment Outcome of Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer

Jian Zhang, Leiping Wang, Xichun Hu, 2022, Cancers.

Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis

S. Zhang, Jian Zhang, Leiping Wang, 2020, Cancer research and treatment : official journal of Korean Cancer Association.

Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score–matched analysis of real-world data

Jian Zhang, Leiping Wang, Xichun Hu, 2022, Therapeutic advances in drug safety.

Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial

Jian Zhang, Leiping Wang, Zhonghua Wang, 2018, BMC Cancer.

Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial

Ting Li, Jian Zhang, Leiping Wang, 2021, Investigational New Drugs.

PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib

Zhen Jia, Jian Zhang, Si Sun, 2011, BMC Cancer.

Depletion of SENP1 suppresses the proliferation and invasion of triple-negative breast cancer cells.

Jian Zhang, Leiping Wang, Zhonghua Wang, 2016, Oncology reports.

Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer

Z. Shao, Jialei Wang, S. Fais, 2015, Journal of experimental & clinical cancer research : CR.

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer

Z. Shao, Jian Zhang, Leiping Wang, 2018, BMC Cancer.

Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer

Ting Li, Jian Zhang, Leiping Wang, 2021, Cell Death & Disease.

The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells

Jun Cao, Jian Zhang, Z. Ou, 2015, Medical Oncology.

GSTT1, GSTP1, and GSTM1 genetic variants are associated with survival in previously untreated metastatic breast cancer

S. Zhang, Jian Zhang, Leiping Wang, 2017, Oncotarget.

Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation

Ting Li, Jian Zhang, Leiping Wang, 2023, Cancer.

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer

Z. Shao, Jian Zhang, Leiping Wang, 2018, BMC Cancer.

Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancer

Guangyu Liu, Jiong Wu, G. Di, 2015, International journal of cancer.

Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocrine Therapy and Subsequent Therapy: A Real-World Single-Center Retrospective Study in China

Ting Li, Jian Zhang, Leiping Wang, 2020, Medical science monitor : international medical journal of experimental and clinical research.

Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients

Ting Li, Jian Zhang, Leiping Wang, 2020, Frontiers in Oncology.

A preliminary study of 18F-FES PET/CT in predicting metastatic breast cancer in patients receiving docetaxel or fulvestrant with docetaxel

Jian Zhang, Leiping Wang, Biyun Wang, 2017, Scientific Reports.

Treatment after Progression on Fulvestrant among Metastatic Breast Cancer Patients in Clinical Practice: a Multicenter, Retrospective Study

P. Yuan, Jian Zhang, Leiping Wang, 2019, Scientific Reports.

Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer

Z. Shao, Jialei Wang, S. Fais, 2015, Journal of Experimental & Clinical Cancer Research.

Chemokine Decoy Receptor D6 Plays a Negative Role in Human Breast Cancer

Z. Ou, Z. Shao, Leiping Wang, 2008, Molecular Cancer Research.

The p21 Ser31Arg polymorphism and breast cancer risk: a meta-analysis involving 51,236 subjects

Hui Yu, Jialei Wang, Xiao-dong Zhu, 2010, Breast Cancer Research and Treatment.

Optimal duration of prior endocrine therapy predicts the efficacy of Fulvestrant in a real‐world study for patients with hormone receptor‐positive and HER2‐negative advanced breast cancer

Jian Zhang, Leiping Wang, Xichun Hu, 2020, Cancer medicine.

Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience

S. Zhang, Jian Zhang, Leiping Wang, 2020, Therapeutics and clinical risk management.

An integrated bioinformatics analysis to investigate the targets of miR-133a-1 in breast cancer

Ting Li, Jian Zhang, Leiping Wang, 2021, Translational cancer research.

Phase II trail of nab-paclitaxel in metastatic breast cancer patients with visceral metastases

Ting Li, Jian Zhang, Leiping Wang, 2021, BMC Cancer.

Thalidomide enhanced the efficacy of CHOP chemotherapy in the treatment of diffuse large B cell lymphoma: A phase II study

Jian-hua Chang, Leiping Wang, Biyun Wang, 2016, Oncotarget.

Apatinib for metastatic breast cancer in non-clinical trial setting: Satisfying efficacy regardless of previous anti-angiogenic treatment

Zheng Wu, Jian Zhang, Leiping Wang, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

A randomized phase II study of aromatase inhibitors plus metformin in pre-treated postmenopausal patients with hormone receptor positive metastatic breast cancer

S. Zhang, Ting Li, Jian Zhang, 2017, Oncotarget.

PDGFD induces ibrutinib resistance of diffuse large B-cell lymphoma through activation of EGFR

Jian Zhang, Leiping Wang, Xichun Hu, 2020, Molecular medicine reports.

An explorative analysis of the prognostic value of lactate dehydrogenase for survival and the chemotherapeutic response in patients with advanced triple-negative breast cancer

Jian Zhang, Leiping Wang, Zhonghua Wang, 2018, Oncotarget.

miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2

Ming-chuan Zhao, Leiping Wang, Xichun Hu, 2020, Technology in cancer research & treatment.

Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer

Jian Zhang, Leiping Wang, Xichun Hu, 2019, Scientific Reports.

Chemotherapy of metastatic triple negative breast cancer: Experience of using platinum-based chemotherapy

S. Zhang, Ting Li, M. Fan, 2015, Oncotarget.

Lack of association between methylenetetrahydrofolate reductase gene A1298C polymorphism and breast cancer susceptibility

Jialei Wang, Jian Zhang, Leiping Wang, 2011, Molecular Biology Reports.

Mirtazapine, a dopamine receptor inhibitor, as a secondary prophylactic for delayed nausea and vomiting following highly emetogenic chemotherapy: an open label, randomized, multicenter phase III trial

J. Ragaz, Jiong Wu, Z. Shao, 2020, Investigational New Drugs.

Analysis of clinical features, genomic landscapes and survival outcomes in HER2-low breast cancer

Ting Li, Ming-chuan Zhao, Jian Zhang, 2023, Journal of Translational Medicine.

Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer

Guangyu Liu, Z. Shao, Si Sun, 2014, International journal of nanomedicine.

Yajia Gu, Qin Xiao, Jian Zhang, 2020, The oncologist.

Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial

Jian Zhang, Leiping Wang, Zhonghua Wang, 2018, BMC Cancer.

Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia

Bao-ying Yuan, Ting Li, Yizi Jin, 2020, Breast Cancer Research and Treatment.

Biomarker assessment of the CBCSG006 trial: a randomized phase III trial of cisplatin plus gemcitabine compared with paclitaxel plus gemcitabine as first-line therapy for patients with metastatic triple-negative breast cancer

Z. Shao, Leiping Wang, Biyun Wang, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Fulvestrant 500 mg Versus Exemestane in Postmenopausal Women With Metastatic Breast Cancer Resistant to Adjuvant Nonsteroidal Aromatase Inhibitors in Clinical Practice: A Multicenter Retrospective Study.

Wei Li, X. Guan, Jian Zhang, 2019, Clinical breast cancer.

Norepinephrine attenuates CXCR4 expression and the corresponding invasion of MDA-MB-231 breast cancer cells via β2-adrenergic receptors.

Z. Shao, J. Jin, Leiping Wang, 2015, European review for medical and pharmacological sciences.